期刊文献+

Astragalus Salvia Granules to Benefit the Qi (Qishen Yiqi Keli) protects H9C2 cardiomyocytes by suppressing oxidative stress

下载PDF
导出
摘要 Objective:To investigate the effects of Qishen Yiqi Keli(QSYQ;Astragalus Salvia Granules to Benefit the Qi)on ROS scavenging and inhibition of NADPH oxidase in an effort to identify new natural antioxidants.Methods:A total of 23 representative components in QSYQ were investigated,their effects on hydrogen peroxide induced ROS were assayed by dichlorofluorescein assay.Lucigenin chemiluminescence was adopted to test the effect on NADPH oxidase activity in H9C2 cardiomyocyte cells,and pyrogallol autoxidation was adopted to test the superoxide scavenging capacity.Results:Nine compounds in QSYQ could significantly inhibited H2O2-induced ROS increase compared with the model group(P<.05),including tanshinone I,salvianolic acid A,danshinone IIA,and cryptotanshinone from salvia root,luteolin from salvia root,harpagoside,harpagide,and angoroside C from scrophularia root.Nine compounds in QSYQ could significantly inhibited the production ofO2in H9C2 cell.Tanshinone I showed a lowest IC50 value 0.07 mM,the other including salvianolic acid A,cryptotanshinone,and salvianolic acid B,luteolin,isochlorogenic acid C,astragaloside IV,and glycyrrhetinic acid.Licochalcone A inhibited the autoxidation of pyrogallol at a low concentration,and tanshinone I showed no significant inhibitory effect from 2 mM to 20 mM.Conclusion:QSYQ had significant effects on ROS scavenging and inhibition of NADPH oxidase.Tanshinone I and salvianolic acid A are potential NADPH oxidase inhibitors.
出处 《Journal of Traditional Chinese Medical Sciences》 2016年第3期176-183,共8页 中医科学杂志(英文)
基金 a grant from The National Natural Science Fund(No.81403319) Creation for Significant New Drugs Project of China(No.2012ZX09103-201-011)。
  • 相关文献

参考文献4

二级参考文献35

  • 1闫世艳,夏结来,姚晨.中心随机化系统在临床试验中的应用[J].中国循证医学杂志,2005,5(8):632-635. 被引量:18
  • 2Dorman K,Saade GR,Smith H,et al.Use of the World Wide Web in research:Randomization in a multicenter clinical trial of treatment for twin-twin transfusion syndrome.Obstet Gynecol 2000 ;96(4):636-639.
  • 3Scott NW,McPherson GC,Ramsay CR,et al.The method of minimization for allocation to clinical trials:a review.Control Clin Trials 2002; 23 (6):662-674.
  • 4Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: part I. Circulation 2002; 105: 1387 -93.
  • 5Matsui Y, Jia N, Okamoto H, Kon S, Onozuka H, Akino M, et al. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin 11- induced cardiac hypertrophy. Hypertension 2004; 43: 1195-201.
  • 6Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005; 115: 500-8.
  • 7Weseler AR, Bast A. Oxidative stress and vascular function: implica?tions for pharmacologic treatments. Curr Hypertens Rep 2010; 12: 154-61.
  • 8Singh K, Sirokman G, Communal C, Robinson KG, Conrad CH, Brooks WW, et al. Myocardial osteopontin expression coincides with the development of heart failure. Hypertension 1999; 33: 663- 70.
  • 9Jia N, Dong P, Ye Y, Qian C, Dai Q. Allopurinol attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction. Cardiovasc Ther 2012; 30: 117 -23.
  • 10Ceconi C, Cargnoni A, Pasini E, Condorelli E, Curello S, Ferrari R. Evaluation of phospholipid peroxidation as malondialdehyde during myocardial ischemia and reperfusion injury. Am J Physiol 1991; 260: H1057-61.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部